Skip to content
★ Sign in to follow
AK

Arvind Kush

Executive
RayzeBio, Inc.Inhibikase Therapeutics, Inc.
Total declarations
2
Companies
2
▲ Purchases (1 ops.)
€184k
▼ Sales (0 ops.)
—

Latest filing published 23 Oct 2024 for Inhibikase Therapeutics, Inc., €184k.

Filing timeline

BuySale
Arvind Kush

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Arvind Kush: trading record in brief

Arvind Kush has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Inhibikase Therapeutics, Inc. and RayzeBio, Inc. We count 2 filings; the first trade dates from 26 February 2024 and the latest from 21 October 2024.

No open-market sale appears; the market trades are 1 purchase worth €184k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The newest entry dates from 23 October 2024: an open-market purchase of €184k, in Inhibikase Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Arvind Kush

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    DirectorExecutivesInhibikase Therapeutics, Inc.
    198,650 USD34SEC
    145,000 shares@ US$1.37100.0% of flowCommon StockSEC:0000950170-24-116783:0
    Canonical exit: 19 Jan 2025 (T+90)
  • ●
    CHIEF FINANCIAL OFFICERExecutivesRayzeBio, Inc.
    5M USD27SEC
    78,433 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005502:0

2 of 2 declarations